Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 5 August 2026.
Announcements
5,266
Total raised
£159B
disclosed amounts
This month
£244M
raised so far
The strategic backing from Hamamatsu Ventures will support international expansion and technological development.
"This collaboration marks the beginning of an exciting new chapter for us, especially as we expand into the Japanese and Asia markets. Hamamatsu’s support has also been invaluable in our recently established U.S. operation, where their network has been helping us establish critical connections to scale our business."
The Series B round was led by HV Capital and Unbound, with participation from Cristiano Ronaldo, to fund global expansion.
"Backing Bioniq goes beyond just an investment opportunity for me—it’s about aligning with a shared vision for health, performance, and longevity. I have been using their products myself for almost three years. With their personalized health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer."
The pre-seed round was led by Tony Mallin MBE of Star Capital alongside Cambridge Enterprise and Cambridge Angels.
"WYA links people with their peers and strengthens the ability to keep contact with those that you’re out with, even when they’ve wandered away and phone signal is limited. Tamzin and the team have been a dream to work with, with a modern eye for developing customer and venue safety through their stunning app"
Plural led the Series A round to help the London based startup expand its team and scale its super-brain solution.
"This funding is yet another milestone for Oriole following a year of rapid pace and growth. This is a booming market desperate for solutions and our ambition is to create an ecosystem of photonic networking that can reshape this industry by solving today's bottlenecks and enabling greater competition at the GPU layer. Building on decades of research, we're paving the way for faster, more efficient, more sustainable AI."
The funding round was backed by Evenlode Foundation alongside angel investors and a grant from Innovate UK.
"Siloton has brought together a uniquely qualified team that is able to drive forward technology development at an unprecedented pace. This new support will help us take the next step towards commercialisation by shifting gear from R&D to product development. The population of individuals with retinal disease is growing. New, more affordable and accessible OCT systems like our Akepa technology will be critical to serving patients with precision and efficiency. In turn, this could help reduce preventable blindness, save healthcare providers billions of pounds, and reduce pressure on already stretched eye clinics."
